Xigris and Apgar score low - a phase IV clinical study of FDA data
Apgar score low is reported only by a few people who take Xigris.
The phase IV clinical study analyzes which people take Xigris and have Apgar score low. It is created by eHealthMe based on reports of 3,539 people who have side effects while taking Xigris from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3,539 people reported to have side effects when taking Xigris.
Among them, 2 people (0.06%) have Apgar score low.
What is Xigris?
Xigris has active ingredients of drotrecogin alfa (activated). eHealthMe is studying from 3,542 Xigris users for its effectiveness, alternative drugs and more.
What is Apgar score low?
Apgar score low is found to be associated with 599 drugs and 285 conditions by eHealthMe.
Number of Xigris and Apgar score low reports submitted per year:
Time on Xigris when people have Apgar score low *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Apgar score low when taking Xigris *:
- female: 0.0 %
- male: 100 %
Age of people who have Apgar score low when taking Xigris *:
- 0-1: 100 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs people take besides Xigris *:
- Ranitidine: 2 people, 100.00%
- Gentamicin: 2 people, 100.00%
Common side effects people have besides Apgar score low *:
- Respiratory Distress Syndrome (Rds) In Infants (respiratory disease of newborn babies, especially premature babies, characterized by distressful breathing, cyanosis, and the formation of a glassy membrane over the alveoli of the lungs): 2 people, 100.00%
- Premature Baby: 2 people, 100.00%
- Neonatal Hypotension (low blood pressure in neonate): 2 people, 100.00%
- Head Injury: 2 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Xigris and have Apgar score low?Check whether Apgar score low is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Apgar score low and when was it recovered:
Expand to all the drugs that have ingredients of drotrecogin alfa (activated):
Alternative drugs to, pros and cons of Xigris:
- Xigris (3,542 reports)
Common Xigris side effects:
- Thrombocytopenia (decrease of platelets in blood): 843 reports
- Death: 422 reports
- Sepsis (a severe blood infection that can lead to organ failure and death): 234 reports
Browse all side effects of Xigris:a b c d e f g h i j k l m n o p q r s t u v w x y z
Apgar score low treatments and more:
- Apgar score low (2,242 reports)
COVID vaccines that are related to Apgar score low:
- Apgar score low in Moderna COVID Vaccine
- Apgar score low in Pfizer BioNTech Covid Vaccine
- Apgar score low in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Apgar score low:
- Apgar score low (599 drugs)
All the conditions that are associated with Apgar score low:
- Apgar score low (285 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on drotrecogin alfa (activated) (the active ingredients of Xigris) and Xigris (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Uloric and Cardioactive Drug Level Increased - 6 seconds ago
- Zoloft and Gynecomastia - 11 seconds ago
- Strattera and Fluphenazine drug interaction - 16 seconds ago
- Proscar and Bactrim drug interaction - 17 seconds ago
- Hydroxyzine and Ibuprofen drug interaction - 17 seconds ago
- Testosterone and Prednisone drug interaction - 25 seconds ago
- Rituxan and Acne - 25 seconds ago
- Vitamin E and Productive Cough - 37 seconds ago
- Paragard T 380A and Photophobia - 38 seconds ago
- Depo-Provera and Rosacea - 38 seconds ago